Suraksha Diagnostic IPO
Suraksha Diagnostic IPO — date, price band, lot size & details 2024
Suraksha Diagnostic listed on 6 Dec 2024 at ₹438, 0.7% below the ₹441 issue price.
Suraksha Diagnostic offers one-stop pathology, radiology and medical consultation services, mainly in eastern India, through 49 diagnostic centres and 166 collection centres. Its total income was Rs 222.26 crore in FY2024.
Stock price
Suraksha Diagnostic is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 11 November.
- Open 29 Nov 2024
- Close 03 Dec 2024
- Allotment 04 Dec 2024
- Refund/credit 05 Dec 2024
- Listing 06 Dec 2024
Issue summary
The terms of the offer, as filed.
| IPO Dates | 29 Nov to 3 Dec, 2024 |
|---|---|
| Price Band | ₹420 – ₹441 |
| Face Value | ₹2 |
| Lot Size | 34 Shares |
| Issue Size | ₹846.25 Cr |
| Sale Type | OFS only |
| Listing On | BSE, NSE |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 14,994 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 34 shares at the ₹441 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 34 | ₹14,994 |
| Retail (max) | 13 | 442 | ₹1,94,922 |
| S-HNI (min) | 14 | 476 | ₹2,09,916 |
| S-HNI (max) | 66 | 2,244 | ₹9,89,604 |
| B-HNI (min) | 67 | 2,278 | ₹10,04,598 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 5
- 01Profit after tax rose from Rs 6.07 crore in FY2023 to Rs 23.13 crore in FY2024.
- 02Borrowing was low at Rs 7.57 crore on 30 June 2024.
- 03It runs 215 customer touchpoints across eastern India.
- 04Net worth grew from Rs 145.84 crore on 31 March 2022 to Rs 187.05 crore on 30 June 2024.
- 05The source puts return on net worth at 14.09%.
Risks · 5
- 01The whole Rs 846.25 crore issue was offer for sale, so no money went to the company.
- 02The pre-issue P/E was 99.31 at the upper band of Rs 441, based on EPS of Rs 4.44.
- 03Total income fell from Rs 225.77 crore in FY2022 to Rs 193.69 crore in FY2023, so growth has been uneven.
- 04The business is concentrated in eastern India, with 49 diagnostic centres, and faces strong competition from national chains.
- 05Promoters and the promoter group held 61.07% before the issue and 48.78% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Suraksha Diagnostic offer document.
| Metric | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 314.20 | 300.21 | 281.20 | 275.96 |
| Total Income | 61.85 | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 |
| NET Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Reserves and Surplus | 176.80 | 170.88 | 147.40 | 137.31 |
| Total Borrowing | 7.57 | 8.64 | 14.01 | 19.03 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Suraksha Diagnostic RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Suraksha Diagnostic IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Pre-Issue | Post-Issue |
|---|---|---|
| EPS (₹) | ₹4.44 | ₹5.89 |
| P/E Ratio (x) | 99.31 | 74.89 |
| Market Cap at Offer Price (₹ Cr) | ₹761.82 | ₹574.27 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹441 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
How the company intends to use the proceeds of the issue.
Information about the usage of proceeds from the Suraksha Diagnostic IPO will be updated shortly.
About the company
Its services include X-rays, ultrasonography, CT, MRI and vaccinations, through a central reference laboratory, 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres, as of 30 June 2024.
Its promoters are Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma.
The IPO was Rs 846.25 crore and was entirely an offer for sale by the three promoters and investors, so the company received none of the money.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Suraksha Diagnostic IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Nuvama Wealth Management Ltd.
42 issues handledBest listing: Gandhar Oil Refinery (India) (+76.3%). Weakest: ACME Solar Holdings (-13.1%).
SBI Capital Markets Ltd.
70 issues handledBest listing: Bajaj Housing Finance (+114.3%). Weakest: Kalyan Jewellers India (-15.0%).
ICICI Securities
133 issues handledBest listing: Latent View Analytics (+160.0%). Weakest: Shriram Properties (-23.7%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Suraksha Diagnostic?
The current Grey Market Premium is ₹12, or 3% over the issue price.
What is the Suraksha Diagnostic IPO price band?
₹420 to ₹441, on a face value of ₹2.
When is the allotment?
The basis of allotment is 4 December 2024, with listing on 6 December 2024.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
